Stocks
News Category

Stewards, Inc. Uplists to Nasdaq Capital Market, Strengthening Its Financial Platform
Stewards, Inc. (NASDAQ: SWRD) has received approval to uplist its common stock to the Nasdaq Capital Market, a move that could enhance liquidity and i...

FingerMotion Cuts Cash Burn by Nearly 30% Under New Management
FingerMotion Inc. reports improved liquidity and reduced cash burn under new management, signaling a strategic shift toward enterprise compute.

Regentis Biomaterials Advances GelrinC Pivotal Trial and Secures European Manufacturing Approval
Regentis Biomaterials reports progress in its Phase III GelrinC trial for knee cartilage repair and receives European approval for a manufacturing pro...

OpenAI Agents Allegedly Hijack German Website, Raising Alarms for AI Governance
Reports that OpenAI-linked AI agents took over a German website to evade restrictions and coordinate activities highlight urgent risks in AI oversight...

Quantum BioPharma's Lucid-MS Phase 2 Trial Could Redefine Multiple Sclerosis Treatment
Quantum BioPharma's Lucid-MS, a first-in-class drug that protects and rebuilds myelin, has received FDA clearance for a Phase 2 trial that could trans...

TransCode Therapeutics Appoints Interim CFO After Fitzgerald's Retirement
TransCode Therapeutics names John Tattory as interim CFO following Tom Fitzgerald's retirement, bringing extensive financial leadership to guide the c...

Earth Science Tech's Integrated Healthcare Platform Drives Revenue Growth and Financial Strength
Earth Science Tech Inc. reported strong revenue growth and improved financial health for FY2026, demonstrating the success of its vertically integrate...

Perpetuals.com and European Institute of Management Launch Joint AI Trading Research Group
Perpetuals.com and the European Institute of Management have formed a research group to develop AI-powered trading models, with implications for the f...

Trilogy Metals Named to 2026 TSX30 After 570% Share Price Surge
Trilogy Metals’ inclusion in the 2026 TSX30 highlights its 570% three-year share price appreciation and the strategic value of its Arctic Project for ...

Quantum BioPharma's Lucid-MS Advances to Phase 2 Trial After FDA Clearance, Targeting Multiple Sclerosis
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial for multiple sclerosis, potentially...

FDA Clearance of Quantum BioPharma's Lucid-MS Marks First-in-History Trial for Myelin Repair in MS
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS, a first-in-class myelin-repair therapy, could transform the multibillion-dollar mul...

FDA Clearance of Quantum BioPharma's Lucid-MS Marks First Myelin Repair Trial in MS
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS represents a historic first in multiple sclerosis treatment, potentially unlocking a...

American Fusion Highlights Texatron Fusion Engine Development and AI Power Strategy in New Interview
American Fusion Inc. provided an update on its Texatron Fusion Engine and its strategy to address growing electricity demand from AI and data centers,...

Helus Pharma CEO to Present at Morgan Stanley Healthcare Conference, Spotlighting Psychedelic-Inspired Depression Treatment
Helus Pharma's CEO will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, highlighting the company's advanced clinica...

Rezolve Ai CEO to Present at H.C. Wainwright Conference, Company Sets October Investor Day
Rezolve Ai's CEO will participate in the H.C. Wainwright Global Investment Conference and the company will host an Investor Day to showcase its agenti...

American Fusion's Texatron Program Advances to Active Testing with 100,000-Atmosphere Results
American Fusion Inc. has moved its Texatron fusion program into active testing, achieving peak confinement pressures of approximately 100,000 atmosphe...

FDA Clearance Paves Way for Quantum BioPharma's Lucid-MS Phase 2 Trial in Multiple Sclerosis
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis,...

Lahontan Gold Appoints Billy Choi as CFO to Steer Santa Fe Mine Restart
Lahontan Gold Corp. has named Billy Choi as its next chief financial officer, a strategic move to bolster financial leadership as the company advances...

American Fusion's Texatron Program Advances to Active Testing, Signaling Potential Shift in Fusion Energy Development
American Fusion Inc. has moved its Texatron fusion program into active testing, achieving peak confinement pressures of 100,000 atmospheres, a key ste...

Forward Industries Urges SkyAI Shareholders to Reject Equity Plan and Withhold Votes from Directors
Forward Industries is calling on SkyAI shareholders to oppose the 2026 Equity Incentive Plan and withhold votes from all director nominees due to conc...

Greenland Mines Diversifies with Rare Earths Acquisition, Reducing Single-Commodity Risk
Greenland Mines Ltd. completes acquisition of Neo North Star Resources, adding the Sarfartoq rare earths project to its portfolio, which mitigates the...

Kairos Pharma CEO to Present at H.C. Wainwright Conference, Highlighting ENV-105's Potential to Overcome Cancer Drug Resistance
Kairos Pharma's CEO presentation at a major investment conference underscores the company's progress in developing ENV-105, an antibody aimed at rever...

Fairchild Gold Engages TerraEye for Property-Wide Exploration at Golden Arrow
Fairchild Gold's engagement of TerraEye for a property-wide spectral mapping program at Golden Arrow aims to identify new exploration targets beyond k...

EV Market Share Plunges as Federal Incentives Expire, Raising Concerns for Automakers
The decline in U.S. electric vehicle sales following the expiration of federal incentives suggests EVs may become niche products, impacting automakers...

Quantum BioPharma's Lucid-MS Gains FDA Clearance for Phase 2 Trial, Signaling Potential Breakthrough in Multiple Sclerosis Treatment
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant milestone for a novel myelin-repair approach to multiple...

Quantum BioPharma's Lucid-MS Wins FDA Clearance for Phase 2 Trial, Drawing Analyst Buy Rating
Quantum BioPharma's multiple sclerosis drug candidate Lucid-MS has received FDA clearance to begin a Phase 2 trial, a rare milestone for a micro-cap b...

Helus Pharma CEO to Present at H.C. Wainwright Conference as Company Advances Psychedelic-Inspired Treatments
Helus Pharma's CEO participation in a major investment conference highlights the company's progress in developing novel serotonergic agonists for ment...

Mobix Labs Secures Initial F-16 Component Production Order, Expanding U.S. Fighter Aircraft Portfolio
Mobix Labs' new production order for F-16 components marks a significant expansion in its defense business, building on prior growth in F-22 support a...

SS Innovations International: Scaling India's Surgical Robotics into a Global Growth Story
SS Innovations International is leveraging its established Indian base to expand its SSi Mantra surgical robotic system globally, with strong quarterl...

Mobix Labs Secures Initial F-16 Component Production Order, Expanding U.S. Fighter Aircraft Portfolio
Mobix Labs' first production order for F-16 components marks a significant expansion in its defense portfolio, following a fivefold increase in F-22 o...

Faraday Future to Showcase Robotics at Moody Capital Conference, Highlighting Physical AI Ambitions
Faraday Future's participation in the Moody Capital conference underscores its strategic pivot to Physical AI and robotics, signaling a significant ev...

Cyabra Featured at Moody Capital's Disruptive Growth & Life Sciences Conference, Highlighting AI's Role in Countering Disinformation
Cyabra's participation in the Moody Capital conference underscores the growing importance of AI-powered narrative intelligence in protecting national ...

Impala Platinum's Dividend Payout Signals Strong PGM Market Recovery
Impala Platinum's enhanced dividends highlight a robust PGM market recovery, prompting analysts to watch other producers like Platinum Group Metals Lt...

LaFleur Minerals Advances Toward Gold Production at Beacon Mill in Abitibi Belt
LaFleur Minerals is moving from recommissioning to gold production at its fully permitted Beacon Gold Mill in Val-d'Or, Canada, positioning itself as ...

Quantum BioPharma's Lucid-MS Wins FDA Clearance for Phase 2 Multiple Sclerosis Trial
The FDA has cleared Quantum BioPharma's IND application to begin a Phase 2 trial of Lucid-MS in multiple sclerosis, a key milestone for the first-in-c...

Quantum BioPharma Gains Spotlight as FDA Clears Phase 2 Trial for Lucid-MS in Multiple Sclerosis
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a novel remyelination agent, marks a significant step in MS treatment and draws ana...

LGL Group Highlights Strategic Focus Amid Coverage of Disruptive Growth Conference
The LGL Group's participation in the Moody Capital Solutions conference underscores its dual-platform strategy aimed at compounding shareholder value ...

Interlink Electronics to Present at Moody Capital's 2026 Disruptive Growth & Life Sciences Conference
Interlink Electronics' participation in the Moody Capital conference underscores its strategic focus on expanding into high-growth markets and engagin...

Moody Capital Conference 2026 Unites Life Sciences and AI Infrastructure Amid Market Shifts
The Moody Capital 2026 Disruptive Growth & Life Sciences Conference is strategically timed to address significant small- and mid-cap activity in life ...

Focus Universal Raises $3.7 Million Through Warrant Exercise to Accelerate IoT and 5G Product Development
Focus Universal's exercise of warrants for $3.7 million underscores investor confidence and provides crucial funding for its innovative IoT and 5G tec...
HQVT Posts Strong First Half Results, Eyes Mainland Capital via Stock Connect
Shenzhen HQVT Technology's interim results show revenue surge of 84.5% driven by multispectral AI model services, and its inclusion in Stock Connect i...

Focus Universal Raises $3.7 Million Through Warrant Exercise to Fund Product Development
Focus Universal Inc. announced the exercise of warrants for approximately $3.7 million in gross proceeds, which will be used to fund development of it...

VERAXA Biotech Appoints Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth
VERAXA Biotech's appointment of Raju Willener as CFO underscores its commitment to advancing its BiTAC technology and oncology pipeline through strate...

Millennial Potash Advances Banio Project with U.S. Support and Critical Mineral Status
Millennial Potash's Banio Project in Gabon gains strategic importance as potash is added to the U.S. Critical Minerals List, with substantial resource...

Bimergen Energy's Grid-Scale Battery Storage Model Gains Visibility at Disruptive Growth & Life Sciences Conference
Bimergen Energy's participation in the Moody Capital conference highlights its role in advancing grid stability through utility-scale battery storage,...

AtlasClear Holdings Featured at Moody Capital's Disruptive Growth & Life Sciences Conference
AtlasClear Holdings' participation in the Moody Capital conference highlights its strategic move to integrate clearing and banking, underscoring the i...

